Skip to content
value.today

Amgen Inc. vs Gilead Sciences, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Amgen Inc. is the larger company by market value: $249.2 B against $193.5 B for Gilead Sciences, Inc., 1.3 times as much (market caps of Oct 30, 2026 for Amgen Inc. and Oct 26, 2026 for Gilead Sciences, Inc.).
  • Amgen Inc. had more revenue: $36.8 B against $29.4 B for Gilead Sciences, Inc., both in the year to December 2025.
  • Gilead Sciences, Inc. earned more: net income of $8.5 B against $7.7 B for Amgen Inc.
  • Gilead Sciences, Inc. keeps more of each dollar of sales: a net margin of 28.9% against 21.0% for Amgen Inc.
  • Amgen Inc. employs more people: 25,200 against 17,000 at Gilead Sciences, Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $1,731,941 at Gilead Sciences, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0581171752342020202120222023202420252026Amgen Inc. 173Gilead Sciences, Inc. 234

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$9B$18B$28B$37B201720182019202020212022202320242025Amgen Inc. $37BGilead Sciences, Inc. $29B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAmgen Inc.
AMGN · #73 in the world
Gilead Sciences, Inc.
GILD · #104 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19801987
Size
Market cap$249.2 B$193.5 B
Revenue$36.8 B$29.4 B
Net income$7.7 B$8.5 B▲ best
Employees25,20017,000
Valuation
P/E ratio26.5×—
Price to sales6.4×6.3×
Price to book28.8×8.5×
Free cash flow yield3.3%4.9%▲ best
Profitability
Gross margin67.3%—
Operating margin24.7%—
Net margin21.0%—
Return on equity106.1%—
Return on invested capital14.4%—
Growth
Revenue growth9.9%—
Revenue growth, 3 years a year11.8%—
Earnings per share growth88.2%—
Financial strength
Debt to equity6.3×—
Net debt to EBITDA3.2×—
Interest cover3.3×—
Cash
Free cash flow margin22.0%—
Shareholder returns
Dividend yield2.1%—
Shareholder yield2.1%—
Strength scores
Piotroski F-score7 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Amgen Inc. or Gilead Sciences, Inc.?

Amgen Inc. is the larger company by market value: $249.2 B against $193.5 B for Gilead Sciences, Inc., 1.3 times as much (market caps of Oct 30, 2026 for Amgen Inc. and Oct 26, 2026 for Gilead Sciences, Inc.).

Which makes more money, Amgen Inc. or Gilead Sciences, Inc.?

Amgen Inc. had more revenue: $36.8 B against $29.4 B for Gilead Sciences, Inc., both in the year to December 2025. Gilead Sciences, Inc. earned more: net income of $8.5 B against $7.7 B for Amgen Inc.

Which is more profitable, Amgen Inc. or Gilead Sciences, Inc.?

Gilead Sciences, Inc. keeps more of each dollar of sales: a net margin of 28.9% against 21.0% for Amgen Inc.

Which has more employees, Amgen Inc. or Gilead Sciences, Inc.?

Amgen Inc. employs more people: 25,200 against 17,000 at Gilead Sciences, Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $1,731,941 at Gilead Sciences, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.